(MedPage Today) — The use of potent aldehyde dehydrogenase 1 A1 (ALDH1A1)-activating proton pump inhibitors (PA-PPIs) was associated with inferior survival outcomes in patients with newly diagnosed glioblastoma, according to a retrospective meta…
Webinar on allied health and nursing to be held on May 11
With the growing demand for quality healthcare services, allied health and nursing professionals are playing an increasingly significant role in...






